Active hexose correlated compound (AHCC) enhances resistance to infection in a mouse model of surgical wound infection

Surgical Infections

Volumn 7, Issue 6, 2006, Pages 527-535

  Aviles, Hernan ^a   O'Donnell, Phyllis ^a   Sun, Buxiang ^b   Sonnenfeld, Gerald ^a  

^a BINGHAMTON UNIVERSITY   (United States)

^b Amino Up Chemical Co   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEXOSE; IMMUNOMODULATING AGENT; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DEATH; DIET RESTRICTION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; FEMALE; FOOD INTAKE; IMMUNE RESPONSE; INFECTION RESISTANCE; KLEBSIELLA PNEUMONIAE; LD 50; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURGICAL INFECTION; SURGICAL TECHNIQUE; SURVIVAL;

ADMINISTRATION, ORAL; ANIMALS; FEMALE; HUMANS; IMMUNITY, NATURAL; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LETHAL DOSE 50; MICE; POLYSACCHARIDES; SPECIFIC PATHOGEN-FREE ORGANISMS; SURGICAL WOUND INFECTION;

EID: 33847408946     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2006.7.527     Document Type: Article

References (52)

1. Heldricks DL, Polk HC Jr, Fry DE. Surgical aspects of infection. In: Goldsmith H, ed. The Practice of Surgery. Hagerstown. Harper and Row, 1987:1-33.
2. Altemeier WA. Sepsis in surgery: Presidential address. Arch Surg 1982;117:107-112.
3. Gottrup F, Melling A, Hollander DA. An overview of surgical site infections: Aetiology, incidence and risk factors. World Wide Wounds [http://www.worldwidewounds.com] 2005.
4. Goris RJ, Draaisma J. Causes of death after blunt trauma. J Trauma 1982;22:141-146.
5. Polk HC Jr, Cheadle WG, Sonnenfeld G, et al. Infection associated with the surgical care of the major trauma victim. In: Jaffe H, Bucalo B, Sherwin S, eds. Antiinfective Application of Interferon-Gamma. New York. Marcel Dekker, 1992:9-36.
6. Miller SE, Miller CL, Trunkey DD. The immune consequences of trauma. Surg Clin North Am 1982;62:167-181.
7. Polk H Jr, Wellhausen SR, Regan MP, et al. A systematic study of host defense processes in badly injured patients. Ann Surg 1980;204:282-299.
8. Rodrick ML, Wood JJ, O'Mahony JB, et al. Mechanisms of immunosuppression associated with severe nonthermal traumatic injuries in man: production of interleukin 1 and 2. J Clin Immunol 1986;6:310-318.
9. Faist E, Mewes A, Strasser T, et al. Alteration of monocyte function following major injury. Arch Surg 1988;123:287-292.
10. Freitag KA, Saker KE, Thomas E, et al. Acute starvation and subsequent refeeding affect lymphocyte subsets and proliferation in cats. J Nutr 2000;130:2444-2449.
11. Pallinger E, Csaba G. Influence of acute stress on the triiodothyronine (T3) and serotonin content of rat's immune cells. Acta Physiol Hung 2005;92:47-52.
12. Duggal PS, Ryan NK, Van der Hoek KH, et al. Effects of leptin administration and feed restriction on thecal leucocytes in the preovulatory rat ovary and the effects of leptin on meiotic maturation, granulosa cell proliferation, steroid hormone and PGE2 release in cultured rat ovarian follicles. Reproduction 2002;123:891-898.
13. Galland RB, Polk HC Jr. Non-specific stimulation of host defenses against a bacterial challenge in malnourished hosts. Br J Surg 1982;69:665-668.
14. Polk HC Jr, Cheadle WG, Livingston DH, et al. A randomized prospective clinical trial to determine the efficacy of interferon-γ in severely injured patients. Am J Surg 1992;193:191-196.
15. Atchinson JM, Arbuckle DD. Anti-endotoxin in the treatment of severe surgical septic shock: Results of a randomized double-blind trial. S Afr Med J 1985;68:787-789.
16. Gluck D, Wiedeck H, Van Wickern M, et al. Antilipopolysaccharide- immunoglobulin (IgG-anti LPS) therapy in intensive care patients following surgery from infectious disease. Infusiontherapie 1990;17:220-223.
17. Abraham E, Wunderink R, Silverman H, et al. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome: A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha Mab Sepsis Study Group. JAMA 1995;273:934-941.
18. Reinhart K, Menges T, Gardlund B, et al. Randomized placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The Ramses Study. Crit Care Med 2001;29:765-769.
19. Hershman MJ, Sonnenfeld G, Mays BW, et al. Effects of interferon-γ treatment on surgically simulated wound infection in mice. Microb Pathog 1988;4:165-168.
20. Kidd PM. The use of mushrooms glucans and proteoglycans in cancer treatment. Altern Med Rev 2000;5:4-27.
21. Ghoneum M, Wimbley M, Salem F, et al. Immunomodulatory and anticancer effects of active hemicellulose compound (AHCC). Int J Immunother 1995;21:23-28.
22. Matsushita K, Kuramitsu Y, Ohiro Y, et al. Combination therapy of active hexose correlated compound plus UFT significantly reduces the metastasis of rat mammary adenocarcinoma. Anticancer Drugs 1998;9:343-350.
23. Wang S, Wakame K, Igarashi Y, et al. Beneficial effects of active hexose correlated compound on immobilization stress in the rat. Dokkyo J Med Sci 2001;28:559-565.
24. Ikeda T, Ishibashi H, Fujisaki R, et al. Prophylactic efficacy of a basidiomycetes preparation AHCC against lethal Candida albicans infection in experimental granulocytopenic mice. Nippon Ishinkin Gakkai Zasshi 2003;44:127-131.
25. Gao Y, Zhang D, Sun B, et al. Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses. Cancer Immunol Immunother 2005;16:1-9.
26. Aviles H, Belay T, Fountain K, et al. Increased susceptibility to Pseudomonas aeruginosa infection under hindlimb unloading conditions. J Appl Physiol 2003;95:73-80.
27. Aviles H, Belay T, Vance M, et al. Active hexose correlated compound enhances the immune function of mice in the hindlimb-unloading model of space flight conditions. J Appl Physiol 2004;97:1437-1444.
28. Borchers AT, Stern JS, Hackman RM, et al. Mushrooms, tumors, and immunity. Proc Soc Exp Biol Med 1999;221:281-293.
29. Burikhanov RB, Wakame K, Igarashi Y, et al. Suppressive effect of active hexose correlated compound (AHCC) on thymic apoptosis induced by dexamethasone in the rat. Endocr Regul 2000;34:181-188.
30. Mamdooh G, Phyllis P, Yasuo N, et al. Enhancement of NK cell activity in cancer patients by active hemicellulose compound (AHCC). Presented at the Adjuvant Nutrition in Cancer Treatment Symposium. Tulsa, Oklahoma, November 6-7, 1992.
31. Wakame K. Protective effects of active hexose correlated compound (AHCC) on the onset of diabetes in the rat. Biomed Res 1999:145-152.
32. Ye SF, Wakame K, Ichimura K, et al. Amelioration by active hexose correlated compound of endocrine disturbances induced by oxidative stress in the rat. Endoer Regul 2004; 38:7-13.
33. Ye SF, Ichimura K, Wakame K, et al. Suppressive effects of active hexose correlated compound on the increased activity of hepatic and renal ornithine decarboxylase induced by oxidative stress. Life Sci 2003;74:593-602.
34. Matsui Y, Uhara J, Satoi S, et al. Improved prognosis of postoperative hepatocellular carcinoma patients when treated with functional foods: A prospective cohort study. J Hepatol 2002;37:78-86.
35. Yagita A, Maruyama S, Wakasugi S, et al. H-2 haplotype-dependent serum IL-12 production in tumor-bearing mice treated with various mycelial extracts. In vivo 2002;16:49-54.
36. Hershman MJ, Polk HC Jr, Pietsch JD, et al. Modulation of Klebsiella pneumoniae infection of mice by interferon-γ. Clin Exp Immunol 1988;72:406-409.
37. Reed LJ, Muench H. A simple method of estimating fifty percent end points. Am J Hyg 1938;27:493-497.
38. Aviles H, Monroy FP. Toxoplasma gondii: Cold stress-induced modulation of antibody responses. Exp Parasitol 2001;99:89-96.
39. Putwatana RN, Reodecha P, Sirapongam Y, et al. Nutrition screening tools and the prediction of postoperative infectious and wound complications: Comparison of methods in presence of risk adjustment. Nutrition 2005;21:691-697.
40. Schneider SM, Veyres P, Pivot X, et al. Malnutrition is an independent factor associated with nosocomial infections. Br J Nutr 2004;92:105-111.
41. Belay T, Aviles H, Vance M, et al. Effects of the hindlimb-unloading model of space flight conditions on resistance of mice to infection with Klebsiella pneumoniae. J Allergy Clin Immunol 2002;110:262-268.
42. Aviles H, Belay T, Fountain K, et al. Active hexose correlated compound enhances resistance to Klebsiella pneumoniae infection in mice in the hindlimb-unloading model of spaceflight conditions. J Appl Physiol 2003;95:491-496.
43. Aviles H, Belay T, Vance M, et al. Effects of space flight conditions on the function of the immune system and catecholamine production simulated in a rodent model of hindlimb unloading. Neuroimmunomodulation 2005;12:173-181.
44. Oarada M, Nikawa T, Kurita N. Effect of timing of food deprivation on host resistance to fungal infection in mice. Br J Nutr 2002;88:151-158.
45. Duclos M, Bouchet M, Vettier A, et al. Genetic differences in hypothalamic-pituitary-adrenal axis activity and food restriction-induced hyperactivity in three inbred strains of rats. J Neuroendocrinol 2005;17:740-752.
46. Karteris E, Machado RJ, Chen J, et al. Food deprivation differentially modulates orexin receptor expression and signaling in rat hypothalamus and adrenal cortex. Am J Physiol Endocrinol Metab 2005;288:E1089-E1100.
47. Crespi EJ, Denver RJ. Ancient origins of human developmental plasticity. Am J Hum Biol 2005;17:44-54.
48. Jhanwar-Uniyal M, Darwish M, Levin BE, et al. Alterations in catecholamine levels and turnover in discrete brain areas after food deprivation. Pharmacol Biochem Behav 1987;26:271-275.
49. Lyte M, Ernst S. Catecholamine induced growth of gram-negative bacteria. Life Sci 1992;50:203-213.
50. Belay T, Aviles H, Vance M, et al. Catecholamines and in vitro growth of pathogenic bacteria: enhancement of growth varies greatly among bacterial species. Life Sci 2003;73:1527-1535.
51. Lyte M. Microbial endocrinology and infectious disease in the 21st Century. Trends Microbiol 2004;12:14-20.
52. Lyte M, Erickson AK, Arulanandam BP, et al. Norepinephrine-induced expression of the K99 pilus adhesin of enterotoxigenic Escherichia coli. Biochem Biophys Res Commun 1997;232:682-686.